SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-051490
Filing Date
2021-08-13
Accepted
2021-08-13 18:59:58
Documents
2
Period of Report
2021-08-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3447
2 POA DOCUMENT poa.txt EX-24.4_1003915 3104
  Complete submission text file 0001209191-21-051490.txt   7894
Mailing Address 2100 POWELL STREET SUITE 900 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 900 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Issuer) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 39 YORKSHIRE DR OAKLAND CA 94618
Business Address
Novack David F (Reporting) CIK: 0001573072 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34207 | Film No.: 211173826